Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

Shanrong Biotechnology Corp. SRBT

Set alert

Price alert · SRBT

All alert types
0.00 USD 0.00 0.00%

At close · Oct 30

0.10 Day range 0.10
0.0001 52-week range 0.22405
YTD
-99.90%
1 year
-99.94%
Open
0.10
Prev close
0.0001
Mkt cap
100.05K
Vol
6.60K
Avg vol
0
EPS
0.00
P/E
0.00
More statistics
Low
0.10
High
0.10

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for SRBT has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-9896.49 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

0 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -2.0×
FY 2008: -0.1×FY 2009: -0.1×FY 2014: -251×FY 2015: -251×FY 2016: -18.5×FY 2017: -16.5×FY 2018: 0.0×FY 2022: -4.7×FY 2023: -11.8×FY 2024: -2.0×
FY 2008 5y median -4.7× FY 2024
P/S 0.0×
FY 2008: 0.5×FY 2009: 0.3×FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×
FY 2008 5y median 0.0× FY 2024
P/B 0.0×
FY 2008: -0.1×FY 2009: -0.1×FY 2014: -253×FY 2015: -126×FY 2016: -70.2×FY 2017: -13.4×FY 2018: 166×FY 2022: -4.7×FY 2023: -0.3×FY 2024: 0.0×
FY 2008 5y median -0.3× FY 2024
P/FCF 0.0×
FY 2008: -0.2×FY 2009: -0.4×FY 2014: 0.0×FY 2015: 0.0×FY 2016: -30.3×FY 2017: -16.5×FY 2018: 0.0×FY 2022: -4.7×FY 2023: 0.0×FY 2024: 0.0×
FY 2008 5y median 0.0× FY 2024
EV/EBITDA 0.0×
FY 2008: -1.2×FY 2009: -0.5×FY 2014: 0.0×FY 2015: 0.0×FY 2016: -18.5×FY 2017: -15.7×FY 2018: -1.1×FY 2022: -4.4×FY 2023: -11.7×FY 2024: 0.0×
FY 2008 5y median -4.4× FY 2024
EV/Sales 0.0×
FY 2008: 3.9×FY 2009: 1.7×FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×
FY 2008 5y median 0.0× FY 2024
FCF Yield 0.0%
FY 2008: -424.0%FY 2009: -225.7%FY 2014: 0.0%FY 2015: 0.0%FY 2016: -3.3%FY 2017: -6.1%FY 2018: 0.0%FY 2022: -21.2%FY 2023: 0.0%FY 2024: 0.0%
FY 2008 5y median 0.0% FY 2024

Profitability

Gross Margin 0.0%
FY 2008: 100.0%FY 2009: 100.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2008 5y median 0.0% FY 2024
Operating Margin 0.0%
FY 2008: -348.6%FY 2009: -363.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2008 5y median 0.0% FY 2024
Net Margin 0.0%
FY 2008: -392.8%FY 2009: -383.3%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2008 5y median 0.0% FY 2024
ROE 0.0%
FY 2008: 74.5%FY 2009: 127.6%FY 2014: 100.0%FY 2015: 50.0%FY 2016: 379.7%FY 2017: 81.0%FY 2018: 0.0%FY 2022: 102.6%FY 2023: 2.5%FY 2024: 0.0%
FY 2008 5y median 2.5% FY 2024
ROIC 0.0%
FY 2008: 201.4%FY 2009: 231.9%FY 2014: 100.0%FY 2015: 50.1%FY 2016: 408.5%FY 2017: 81.0%FY 2018: 0.0%FY 2022: -479.3%FY 2023: 64.9%FY 2024: 0.0%
FY 2008 5y median 0.0% FY 2024
ROA 0.0%
FY 2008: -672.1%FY 2009: -2664.9%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: -128.2%FY 2018: 0.0%FY 2022: -431.7%FY 2023: -865.5%FY 2024: 0.0%
FY 2008 5y median -128.2% FY 2024

Growth (YoY)

Revenue 0.0%
FY 2008: 0.0%FY 2009: 91.3%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2008 FY 2024
Operating Income -43.4%
FY 2008: 0.0%FY 2009: -99.2%FY 2014: 0.0%FY 2015: -0.1%FY 2016: -1268.6%FY 2017: -12.1%FY 2018: -1307.3%FY 2022: 0.0%FY 2023: 79.2%FY 2024: -43.4%
FY 2008 FY 2024
EPS (diluted) -43.5%
FY 2008: 0.0%FY 2009: -72.7%FY 2014: 0.0%FY 2015: 0.0%FY 2016: -1258.1%FY 2017: -12.2%FY 2018: 100.0%FY 2022: 0.0%FY 2023: 78.9%FY 2024: -43.5%
FY 2008 FY 2024
Free Cash Flow 0.0%
FY 2008: 0.0%FY 2009: 45.9%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: -83.5%FY 2018: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2008 FY 2024

Financial Health

Current Ratio 0.0×
FY 2008: 0.1×FY 2009: 0.0×FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.4×FY 2018: 0.0×FY 2022: 10.1×FY 2023: 0.1×FY 2024: 0.0×
FY 2008 5y median 0.1× FY 2024
Quick Ratio 0.0×
FY 2008: 0.1×FY 2009: 0.0×FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.4×FY 2018: 0.0×FY 2022: 10.1×FY 2023: 0.1×FY 2024: 0.0×
FY 2008 5y median 0.1× FY 2024
Debt / Equity 0.0×
FY 2008: -0.7×FY 2009: -0.5×FY 2014: 0.0×FY 2015: 0.0×FY 2016: -0.1×FY 2017: 0.0×FY 2018: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×
FY 2008 5y median 0.0× FY 2024
Net Debt / EBITDA 0.0×
FY 2008: -1.0×FY 2009: -0.4×FY 2014: 0.0×FY 2015: 0.0×FY 2016: -0.0×FY 2017: 0.8×FY 2018: 0.0×FY 2022: 0.2×FY 2023: 0.1×FY 2024: 0.0×
FY 2008 5y median 0.1× FY 2024
Interest Coverage 0.0×
FY 2008: -7.9×FY 2009: -17.8×FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×
FY 2008 5y median 0.0× FY 2024

Dividends

Dividend Yield 0.0%
FY 2008: 0.0%FY 2009: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2008 5y median 0.0% FY 2024
Payout Ratio 0.0%
FY 2008: 0.0%FY 2009: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2008 5y median 0.0% FY 2024

Annual · latest fiscal year ends 2024-12-31